Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CRSP
|
Celgene Corp /De/
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 256,000 Reduced 6.13% |
$5,058,560
$19.76 p/Share
|
Nov 22
2017 |
|
BH
|
Biglari, Sardar
Director |
BUY
Open market or private purchase
|
Indirect | 1,386 Added 0.21% |
$460,083
$331.95 p/Share
|
Nov 22
2017 |
|
SD
|
Icahn Carl C
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 204,364 Added 2.06% |
$3,523,235
$17.24 p/Share
|
Nov 22
2017 |
|
JOE
|
Fairholme Capital Management LLC
Director |
BUY
Open market or private purchase
|
Direct | 39,000 Added 12.88% |
$740,610
$18.99 p/Share
|
Nov 22
2017 |
|
JOE
|
Fairholme Capital Management LLC
Director |
BUY
Open market or private purchase
|
Indirect | 61,000 Added 0.23% |
$1,158,390
$18.99 p/Share
|
Nov 22
2017 |
|
ISR
|
Mark John Austin
VP Finance/Prin Fin&Acct Offic |
BUY
Open market or private purchase
|
Direct | 1,825 Added 20.17% |
$894
$0.49 p/Share
|
Nov 22
2017 |
|
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 35,200 Added 0.22% |
$42,592
$1.21 p/Share
|
Nov 22
2017 |
|
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Nov 22
2017 |
|
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 27,078 Added 0.15% |
$145,950
$5.39 p/Share
|
Nov 22
2017 |
|
SCPH
|
Orbimed Advisors LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 833,333 Added 19.64% |
$11,666,662
$14.0 p/Share
|
Nov 21
2017 |
|
BH
|
Biglari, Sardar
Director |
BUY
Open market or private purchase
|
Indirect | 32 Added 0.0% |
$10,703
$334.47 p/Share
|
Nov 21
2017 |
|
SD
|
Icahn Carl C
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 183,694 Added 3.83% |
$2,996,049
$16.31 p/Share
|
Nov 21
2017 |
|
GE
|
James S Tisch
Director |
BUY
Open market or private purchase
|
Indirect | 3,000,000 Added 16.85% |
$53,699,999
$17.9 p/Share
|
Nov 21
2017 |
|
CHN
|
City Of London Investment Group PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,667 Added 0.21% |
$102,861
$22.04 p/Share
|
Nov 21
2017 |
|
NWBI
|
Ronald J Seiffert
President, CEO |
BUY
Open market or private purchase
|
Direct | 6,300 Added 50.0% |
$102,690
$16.3 p/Share
|
Nov 21
2017 |
|
ISR
|
Mark John Austin
VP Finance/Prin Fin&Acct Offic |
BUY
Open market or private purchase
|
Direct | 5,400 Added 50.0% |
$2,592
$0.48 p/Share
|
Nov 21
2017 |
|
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 3,202 Added 0.23% |
$6,404
$2.0 p/Share
|
Nov 21
2017 |
|
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,798 Added 0.21% |
$13,596
$2.0 p/Share
|
Nov 21
2017 |
|
CBRI
|
Legion Partners Asset Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 200,000 Reduced 8.12% |
-
|
Nov 21
2017 |
|
CJES
|
Solus Alternative Asset Management LP |
SELL
Open market or private sale
|
Indirect | 83,230 Reduced 0.61% |
$2,454,453
$29.49 p/Share
|
Nov 21
2017 |
|
CBRE
|
Value Act Holdings, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 391,004 Reduced 1.38% |
$16,766,252
$42.88 p/Share
|
Nov 21
2017 |
|
QCOM
|
Michelle M Sterling
EVP, Human Resources |
SELL
Open market or private sale
|
Indirect | 7,840 Reduced 77.68% |
$521,987
$66.58 p/Share
|
Nov 21
2017 |
|
KWR
|
Ronald S Ettinger
VP - Human Resources |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 16.3% |
$162,750
$162.75 p/Share
|
Nov 21
2017 |
|
PTC
|
Anthony Dibona
EVP Focused Solutions Group |
SELL
Open market or private sale
|
Direct | 10,929 Reduced 21.69% |
$713,117
$65.25 p/Share
|
Nov 21
2017 |
|
PEN
|
Bridget O'Rourke
Director |
SELL
Open market or private sale
|
Direct | 429 Reduced 18.15% |
$45,731
$106.6 p/Share
|
Nov 21
2017 |
|
KNSL
|
Ann Marie Marson
EVP and Chief Claims Officer |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 6.65% |
$322,500
$43.0 p/Share
|
Nov 21
2017 |
|
MCRN
|
Ccmp Capital, LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 9,683,401 Reduced 100.0% |
$154,934,416
$16.0 p/Share
|
Nov 21
2017 |
|
MCRN
|
Ccmp Capital, LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,290,692 Reduced 100.0% |
$20,651,072
$16.0 p/Share
|
Nov 21
2017 |
|
ZVO
|
Warburg Pincus Private Equity Viii, L.P.
Director |
SELL
Open market or private sale
|
Direct | 7,562,890 Reduced 100.0% |
$59,746,832
$7.9 p/Share
|
Nov 21
2017 |
|
TRU
|
Christopher A Cartwright
President and CEO |
SELL
Open market or private sale
|
Direct | 175,673 Reduced 78.88% |
$9,669,042
$55.04 p/Share
|
Nov 21
2017 |
|
ENPH
|
John Howard Weber
Director |
SELL
Open market or private sale
|
Direct | 20,200 Reduced 100.0% |
$55,146
$2.73 p/Share
|
Nov 21
2017 |
|
PEN
|
James Robert Pray
President, International |
SELL
Open market or private sale
|
Direct | 6,300 Reduced 1.19% |
$674,730
$107.1 p/Share
|
Nov 21
2017 |
|
CVX
|
Patricia E Yarrington
VP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 82,189 Reduced 94.44% |
$9,486,254
$115.42 p/Share
|
Nov 21
2017 |
|
BK
|
Garden Edward P
Director |
SELL
Open market or private sale
|
Indirect | 6,540 Reduced 0.04% |
$343,677
$52.55 p/Share
|
Nov 21
2017 |
|
GDP
|
Franklin Resources Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 100 Reduced 0.0% |
$1,030
$10.3 p/Share
|
Nov 21
2017 |
|
EVR
|
Adam B Frankel
General Counsel |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 3.15% |
$174,760
$87.38 p/Share
|
Nov 21
2017 |
|
PEN
|
Arani Bose
Director |
SELL
Open market or private sale
|
Direct | 13,865 Reduced 2.07% |
$1,488,269
$107.34 p/Share
|
Nov 21
2017 |
|
PEN
|
Adam Elsesser
CEO and President |
SELL
Open market or private sale
|
Direct | 12,559 Reduced 1.09% |
$1,347,078
$107.26 p/Share
|
Nov 21
2017 |
|
PEN
|
Sridhar Kosaraju
President |
SELL
Open market or private sale
|
Indirect | 6,300 Reduced 4.42% |
$674,604
$107.08 p/Share
|
Nov 21
2017 |
|
FRME
|
Michael C Rechin
Director |
SELL
Open market or private sale
|
Direct | 5,332 Reduced 4.55% |
$220,798
$41.41 p/Share
|
Nov 21
2017 |
|
UFCS
|
Michael J. Sheeley
VP/COO - United Life Ins. Co. |
SELL
Open market or private sale
|
Direct | 3,850 Reduced 31.1% |
$184,954
$48.04 p/Share
|
Nov 21
2017 |
|
DAL
|
Peter W Carter
EVP - External Affairs |
SELL
Open market or private sale
|
Direct | 19,809 Reduced 22.8% |
$998,572
$50.41 p/Share
|
Nov 21
2017 |
|
TTF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,970 Reduced 2.47% |
$343,767
$11.1 p/Share
|
Nov 21
2017 |
|
SAIL
|
Thoma Bravo, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,000,000 Reduced 8.8% |
$55,799,999
$11.16 p/Share
|
Nov 21
2017 |
|
PSDO
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 9,200,000 Reduced 13.73% |
$125,211,997
$13.61 p/Share
|
Nov 21
2017 |
|
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 44,515 Reduced 0.07% |
$2,898,372
$65.11 p/Share
|
Nov 21
2017 |
|
MCD
|
Stephen Easterbrook
President and CEO |
SELL
Open market or private sale
|
Direct | 171,577 Reduced 98.39% |
$28,879,842
$168.32 p/Share
|
Nov 21
2017 |
|
ARE
|
Thomas J Andrews
Co-President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 3.52% |
$639,050
$127.81 p/Share
|
Nov 21
2017 |
|
SQ
|
Sarah Friar
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 19,200 Reduced 19.73% |
$907,584
$47.27 p/Share
|
Nov 21
2017 |
|
BECN
|
Ross D Cooper
EVP & General Counsel |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 23.39% |
$119,500
$59.75 p/Share
|
Nov 21
2017 |